The British Journal of Cardiology

This site is intended for UK healthcare professionals

 
BJC_tv_logo_white
Sign in

Highlights from ESC – a UK primary care perspective

10 November 2023
Professor Terry McCormack and Dr Devin Gray recap some of the new evidence presented at the European Society of Cardiology (ESC) 2023 congress with the greatest impact on primary care: a head-to-head comparison of statins, bempedoic acid for reducing LDL cholesterol, and managing the ongoing cardiovascular risks in patients living with, or who have recovered from, cancer.

Dr Devin Grey Portfolio GP
Professor Terry McCormack GP in Whitby, North Yorkshire, Professor of Primary Care Cardiovascular Medicine at Hull York Medical School (HYMS) and Immediate Past President of the British and Irish Hypertension Society

Learning Objectives

  • Understand the primary care focused highlights from ESC 2023, including updates on trials such as STEP-HFpEF, LODESTAR, CLEAR-outcomes, ONCO DVT and more
  • Interpret how these highlights affect our current understanding of different clinical areas, such as heart failure
  • In light of these highlights, understand how we should be treating our primary care patients

Categories

Tags

blank

ESC Congress 2024 highlights – A UK perspective: What’s new in the latest ESC guideline update?

  • Paul Foley, Terry McCormack

AstraZeneca has provided a sponsorship towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia presentations. The remainder of the programme has remained under the full editorial control of the British Journal of Cardiology.

blank

ESC Congress 2024 highlights – A UK perspective: New evidence on cardiovascular medical care

  • Sarah Birkhoelzer, Aaron Henry

AstraZeneca has provided a sponsorship towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia presentations. The remainder of the programme has remained under the full editorial control of the British Journal of Cardiology.

blank

© 2025 Medinews Cardiology Ltd, a wholly-owned subsidiary of OmniaMed Communications Ltd   |   Privacy & cookies policy   |   Terms & conditions

 

Thanks for your feedback. Please note that by including your email address, you are giving permission for us to contact you by email to help resolve any issues.